Immunotherapy in inoperable stage III non-small cell lung cancer: a review

The leading cause of cancer-related deaths in the United States continues to be lung cancer. Approximately 25–30% of patients are diagnosed with locally advanced non-small cell lung cancer (NSCLC). Concurrent chemoradiation with a platinum-based doublet is the current standard of care for patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Natasha A, Otterson, Gregory A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586171/
https://www.ncbi.nlm.nih.gov/pubmed/31258616
http://dx.doi.org/10.7573/dic.212578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586171/
https://www.ncbi.nlm.nih.gov/pubmed/31258616
http://dx.doi.org/10.7573/dic.212578

Ejemplares similares